RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -719.50K | -8.41M | -725.70K | -1.28M | -1.70M |
| Total Depreciation and Amortization | 169.40K | 204.90K | 223.20K | 228.60K | 230.30K |
| Total Amortization of Deferred Charges | 400.00 | -300.00 | 300.00 | -- | -- |
| Total Other Non-Cash Items | -16.00K | 6.65M | -115.40K | 75.70K | 589.40K |
| Change in Net Operating Assets | 382.20K | 1.11M | -225.90K | 208.00K | -9.00K |
| Cash from Operations | -183.50K | -444.60K | -843.50K | -765.50K | -886.70K |
| Capital Expenditure | -17.60K | -16.00K | -9.10K | -100.00 | -9.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -5.00K | -5.60K | -30.90K | 41.80K |
| Cash from Investing | -17.60K | -21.00K | -14.70K | -30.90K | 32.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -63.00K | -85.80K | -58.10K | -57.90K | -56.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 24.60K | -8.40K | -16.20K | -- |
| Cash from Financing | -44.30K | -44.80K | -48.60K | -54.60K | -41.70K |
| Foreign Exchange rate Adjustments | 10.60K | 1.80K | 2.40K | 6.30K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.80K | -508.60K | -904.50K | -844.80K | -906.20K |